Curaleaf Holdings (CURLF) Tax Provisions (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Tax Provisions of $98.7 million for Q1 2026, up 393.3% year-over-year from $20.0 million in Q1 2025, and down 55.57% quarter-over-quarter from $222.2 million in Q4 2025.
Curaleaf Holdings (CURLF) Tax Provisions (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Tax Provisions history runs 8 years deep, the most recent figure standing at $98.7 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 393.3% year-over-year to $98.7 million; the TTM figure through Mar 2026 stood at $259.2 million (up 147.64% YoY), while the FY2025 annual figure was $123.7 million, up 25.89% from the prior year.
- Tax Provisions for Q1 2026 stood at $98.7 million, down from $222.2 million in the prior quarter.
- The five-year high for Tax Provisions was $3.0 billion in Q4 2023, with the low at -$50.0 million in Q3 2022.
- The 5-year median for Tax Provisions is -$31.4 million (2024), against an average of $207.4 million.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions jumped 22084.03% in 2023, then sank 93.2% in 2024.
- Curaleaf Holdings' Tax Provisions stood at -$13.5 million in 2022, then surged by 22084.03% to $3.0 billion in 2023, then tumbled by 93.2% to $202.3 million in 2024, then rose by 9.82% to $222.2 million in 2025, then slumped by 55.57% to $98.7 million in 2026.
- Business Quant data shows CURLF's Tax Provisions at $98.7 million in Q1 2026, $222.2 million in Q4 2025, and -$30.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | -38.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.80 Mn |
| Mar 31, 2026 | 98.71 Mn |
| Dec 31, 2025 | 222.16 Mn |
| Sep 30, 2025 | -30.24 Mn |
| Jun 30, 2025 | -31.38 Mn |
| Mar 31, 2025 | -33.65 Mn |
| Dec 31, 2024 | 202.30 Mn |
| Sep 30, 2024 | -32.57 Mn |
| Jun 30, 2024 | -31.39 Mn |
| Mar 31, 2024 | -40.09 Mn |
| Dec 31, 2023 | 2.97 Bn |
| Sep 30, 2023 | -31.86 Mn |
| Jun 30, 2023 | -41.95 Mn |
| Dec 31, 2022 | -13.53 Mn |
| Sep 30, 2022 | -49.97 Mn |
| Jun 30, 2022 | -49.16 Mn |
| Dec 31, 2021 | -35.13 Mn |
| Sep 30, 2021 | -60.31 Mn |
| Jun 30, 2021 | -42.62 Mn |
| Mar 31, 2021 | -30.71 Mn |